Industry Insights: Converging modalities drive the next wave of bioconjugate therapies

Lauren Coyle, Commissioning Editor, Bioconjugate InsightsAs an editor with extensive experience in bioconjugation (i.e., ADCs, conjugate chemistry, diagnostics and imaging, bi/multi-specifics, targeted delivery, and theranostics), Lauren’s focus is on advancing the field by facilitating and disseminating high-impact research on conjugation technologies and their applications. Lauren works closely with researchers, scientists, and industry professionals to publish cutting-edge studies exploring the latest advances in conjugation chemistry, drug delivery systems, and the development and delivery of targeted therapeutics. In addition to her editorial responsibilities, she maintains a strong network within the biopharma industry, staying up to date with emerging trends and breakthroughs in bioconjugation.